文献速递慢阻肺肺结节与肺癌

肺功能不同,促癌基质基因表达程序存在差异

Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function.
PubMed 文献 · Am J Respir Crit Care Med · 2019-01-01

研究对肺癌与非肺癌受试者的非恶性肺组织进行多组学分析,发现癌症相关基因表达改变主要表现为mRNA翻译效率变化而非mRNA水平改变,且驱动这些翻译程序的分子机制因肺功能而异:正常至轻度肺功能受损者由mTOR通路驱动,重度气流阻塞者由病理性细胞外基质下游通路驱动。

要点

  • 肺癌相关基质基因表达改变以翻译效率调控为主,mRNA水平无相应变化
  • 正常至轻度肺功能受损者,mTOR通路是促癌翻译程序的上游驱动因素
  • 重度气流阻塞者,病理性细胞外基质下游通路驱动促癌翻译程序

核心结论

  • 肺癌患者中激活两种不同的促癌基质基因表达程序,取决于肺功能状态。

研究设计与样本

  • 研究纳入伴或不伴肺癌、覆盖不同肺功能水平的受试者,对非恶性肺组织进行多组学分析以量化转录组、翻译组和蛋白质组。

主要发现

  • 癌症相关基因表达改变主要表现为mRNA翻译效率变化调节蛋白水平,而mRNA水平无相应改变。
  • 正常至轻度肺功能受损者,mTOR通路作为上游驱动因素;重度气流阻塞者,病理性细胞外基质下游通路出现。
  • mTOR和细胞外基质基因表达程序均与先前识别的促癌分泌组激活平行。
  • 原位检查显示基质成纤维细胞表达两种促癌分泌组的癌症相关蛋白:轻度或无气流阻塞者包括IL-6,重度气流阻塞者包括BMP1。

临床怎么用

  • 提示肺癌筛查策略和个体化癌症治疗需考虑患者肺功能状态。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Rationale: Chronic obstructive pulmonary disease is an independent risk factor for lung cancer, but the underlying molecular mechanisms are unknown. We hypothesized that lung stromal cells activate pathological gene expression programs that support oncogenesis.Objectives: To identify molecular mechanisms operating in the lung stroma that support the development of lung cancer.Methods: The study included subjects with and without lung cancer across a spectrum of lung-function values. We conducted a multiomics analysis of nonmalignant lung tissue to quantify the transcriptome, translatome, and proteome.Measurements and Main Results: Cancer-associated gene expression changes predominantly manifested as alterations in the efficiency of mRNA translation modulating protein levels in the absence of corresponding changes in mRNA levels. The molecular mechanisms that drove these cancer-associated translation programs differed based on lung function. In subjects with normal to mildly impaired lung function, the mammalian target of rapamycin (mTOR) pathway served as an upstream driver, whereas in subjects with severe airflow obstruction, pathways downstream of pathological extracellular matrix emerged. Consistent with a role during cancer initiation, both the mTOR and extracellular matrix gene expression programs paralleled the activation of previously identified procancer secretomes. Furthermore, an in situ examination of lung tissue showed that stromal fibroblasts expressed cancer-associated proteins from two procancer secretomes: one that included IL-6 (in cases of mild or no airflow obstruction), and one that included BMP1 (in cases of severe airflow obstruction).Conclusions: Two distinct stromal gene expression programs that promote cancer initiation are activated in patients with lung cancer depending on lung function. Our work has implications both for screening strategies and for personalized approaches to cancer treatment.

来源:Am J Respir Crit Care Med,查看原文。版权归原作者所有。

引用

  1. Sandri BJ, Masvidal L, Murie C, et al. Distinct Cancer-Promoting Stromal Gene Expression Depending on Lung Function. Am J Respir Crit Care Med. 2019. PMID: 30742544. doi:10.1164/rccm.201801-0080OC

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。